DNA.AX(DNA.AX)
DNA.AX
No analyst ratings available
No analyst price targets available for DNA.AX
Analyst coverage may not be available for this symbol
Earnings surprise history unavailable.
No recent analyst actions
| Metric | FY2027E | FY2028E | FY2029E | FY2030E |
|---|---|---|---|---|
| Revenue Avg | $135M | $94M | $99M | $104M |
| Low | $135M | $94M | $99M | $104M |
| High | $135M | $94M | $99M | $104M |
| EBITDA Avg | $-21M | $-15M | $-16M | $-16M |
| Low | $-21M | $-15M | $-16M | $-16M |
| High | $-21M | $-15M | $-16M | $-16M |
| EBIT Avg | $-27M | $-19M | $-20M | $-21M |
| Low | $-27M | $-19M | $-20M | $-21M |
| High | $-27M | $-19M | $-20M | $-21M |
| Net Income Avg | $82M | $31M | $46M | $59M |
| Low | $82M | $31M | $46M | $59M |
| High | $82M | $31M | $46M | $59M |
| EPS Avg | $0.07 | $0.03 | $0.04 | $0.05 |
| Low | $0.07 | $0.03 | $0.04 | $0.05 |
| High | $0.07 | $0.03 | $0.04 | $0.05 |
| Analysts (Rev / EPS) | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 |